To Evaluate Thrombosis Risk in Chemotherapy Patients With Solid Tumors Who Receiving Thrombocytopenia Treatment
Clinical trial NCT05688306 · COMPLETED
Trial details
- NCT number
- NCT05688306
- Sponsor
- Liaoning Cancer Hospital & Institute
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-09-02
- Primary completion
- 2022-05-16
- Enrollment
- 3494
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.